Andrew C. Patt
  • Publications/Presentations
  • News
  • December 2021: I published a blog post about automatic LC/MS parameter calculation with AutoTuner via DataRevenue.com
  • December 2021: A middle author publication I contributed to, “Lipidomics and Redox Lipidomics Indicate Early Stage Alcohol-Induced Liver Damage”, was published in Hepatology Communications
  • November 2021: I published a blog post about chemical class prediction with CANOPUS via DataRevenue.com
  • November 2021: I published a blog post about Feature-based and Ion Identity Molecular Networking via DataRevenue.com
  • September 2021: I presented a poster at MANA 2021, “MetaboSPAN: an R package for functional enrichment analysis of metabolomic and lipidomic data”
  • June 2021: I successfully defended my thesis: “Integrative and Network-Based Approaches for Functional Interpretation of Metabolomic Data”!
  • November 2020: I gave a poster presentation at the Metabolomics society annual meeting, “Improving pathway analysis of lipidomic and metabolomic data through comprehensive functional annotation and network approaches”
  • September 2020: I gave a 15-minute talk at the Metabolomics Association of North America, “Improving pathway analysis of lipidomic and metabolomic data through comprehensive functional annotation and network approaches”
  • August 2020: My first-author publication, “MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in Dedifferentiated Liposarcoma Models”, was published in MDPI Cancers!
  • June 2020: I presented a poster at the American Society for Mass Spectrometry, “MDM2 copy number aberrations alter ceramide glycosylation in liposarcoma tumors, impacting drug response”
  • May 2020: The preprint for a middle-author manuscript I contributed to, “An OpenData portal to share COVID-19 drug repurposing data in real time”, is available on bioRxiv
  • April 2020: I presented a poster at the OSUWMC trainee research day, “MDM2 copy number aberrations alter ceramide glycosylation in liposarcoma tumors, impacting drug response”
  • February 2020: My second-author paper, “Metabolomics and Multi-Omics Integration: A Survey of Computational Methods and Resources” was published in Metabolites!
  • December 2019: My co-first author publication,“Challenges in proteogenomics: a comparison of analysis methods with the case study of the DREAM Proteogenomics Sub-Challenge”, was published in BMC Bioinformatics!
  • October 2019: I presented a poster at the Ohio Mass Spectrometry and Metabolomics Symposium, “MDM2 copy number aberrations alter ceramide glycosylation in liposarcoma tumors, impacting drug response”
  • June 2019: I gave a 20 minute talk at the International Conference on Intelligent Biology and Medicine, “Challenges in proteogenomics: a comparison of analysis methods with the case study of the DREAM Proteogenomics Sub-Challenge”
  • June 2019: I presented a poster at the American Society for Mass Spectrometry Annual Meeting, “MDM2 Alterations Reprogram the Metabolic Functioning of Liposarcoma Cell Lines”
  • May 2019: I presented a poster at the Ohio Cancer Care Center Annual Meeting, “MDM2 Alterations Reprogram the Metabolic Functioning of Liposarcoma Cell Lines”
  • February 2019: I made a post to my blog about using the tidyverse!
  • January 2019: I made a post to my blog about using Emacs for R development!
  • October 2018: I passed my candidacy exam!